Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Sep 29, 2022

Jason Matuszewski, Chief Executive Officer and Chairman of the Board, and Andrew Van Vurst, Chief Operating Officer of BioStem Technologies have a vision to change the paradigm on the use of perinatal tissue for advanced wound care. Their initial target is complex wounds in the lower extremity region, specifically...


Sep 29, 2022

Jason Matuszewski, Chief Executive Officer and Chairman of the Board, and Andrew Van Vurst, Chief Operating Officer of BioStem Technologies have a vision to change the paradigm on the use of perinatal tissue for advanced wound care. Their initial target is complex wounds in the lower extremity region, specifically...


Sep 28, 2022

Sharon L. Rogers Ph.D. is the CEO of AmyriAD Therapeutics and has a deep understanding of the development of drugs to address the impact of Alzheimer's disease. Currently, the most common treatment is Aricept which Sharon developed and brought to market in 1996. Based on recent research, it does not appear that disease...


Sep 28, 2022

Sharon L. Rogers Ph.D. is the CEO of AmyriAD Therapeutics and has a deep understanding of the development of drugs to address the impact of Alzheimer's disease. Currently, the most common treatment is Aricept which Sharon developed and brought to market in 1996. Based on recent research, it does not appear that disease...


Sep 27, 2022

Jack Hoppin Ph.D. Chief Executive Officer and John Babich Ph.D., President and Chief Scientific Officer, and Co-Founders of Ratio Therapeutics aim to develop and produce best-in-class radiopharmaceuticals. Harnessing the power of radiation by making it into an injectable drug, Ratio is creating a way to find tumor cells...